FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...
Meet Era Biology at Africa Health 2022
The 11th annual Africa Health 2022 exhibition will be held in Gallagher Convention Center, Johannesburg, South Africa on 26th-28th October.
Africa Health is t...
Era Biology will host global live webinar at 8th June 2022 8:30 (GMT +08:00). The webinar will be in Spanish. The webinar will focus on using lateral flow assay method to detect carbapenem-resistan...
C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
On May 19th, Era Biology host the global live webinar. The webinar talks about three different solutions using fungus (1-3)-β-D Glucan Test to achieve early and rapid diagnosis of invasive fungal d...